MedTrace Logo

Complete Decongestive Therapy in Breast Cancer-Related Lymphedema

NCT02458391 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-10-24

No results posted yet for this study

Summary

The purpose of this study is to investigate which number of lymphedema therapy treatments/week best reduces upper extremity swelling, increased arm function, and reduces the most lymphedema symptoms.

Conditions

  • Lymphedema of Upper Limb

Interventions

OTHER

Standard of care complete decongestive therapy

Participants will receive standard of care complete decongestive therapy consisting of meticulous skin and nail care, manual lymphatic drainage, compression bandaging, remedial exercises and self-care training.

Sponsors & Collaborators

  • Novacare

    collaborator UNKNOWN

  • Midwestern University

    collaborator OTHER

  • University of Indianapolis

    lead OTHER

Principal Investigators

  • Peter Rundquist, PhD, PT · University of Indianapolis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02458391 on ClinicalTrials.gov